Back to Search Start Over

Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report.

Authors :
Zhang, Qichen
Xie, Peng
Hou, Xiaoming
Zhao, Chengpeng
Duan, Ling
Qiao, Hui
Source :
Journal of Chemotherapy (Taylor & Francis Ltd); Jul2024, Vol. 36 Issue 4, p334-342, 9p
Publication Year :
2024

Details

Language :
English
ISSN :
1120009X
Volume :
36
Issue :
4
Database :
Complementary Index
Journal :
Journal of Chemotherapy (Taylor & Francis Ltd)
Publication Type :
Academic Journal
Accession number :
177943320
Full Text :
https://doi.org/10.1080/1120009X.2023.2276574